Alnylam Pharmaceuticals Aktie
286,10
EUR
-1,30
EUR
-0,45
%
336,23
USD
-3,15
USD
-0,93
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
| 20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
| 03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung